High Technology News and Information for the Rocky Mountain Region
|
High Technology News and Information for the Rocky Mountain Region |
|
Friday, February 15, 2008
Q Therapeutics Gets Investment Salt Lake City, Utah-based Q Therapeutics, which is developing treatments for central nervous systems diseases, has received an investment from California-based Invitrogen, a provider of life sciences technology for the pharmaceutical market. Amount of the investment was not disclosed for the minority investment. Q Therapeutics is developing treatments for CNS diseases and other neurodegenerative diseases, including multiple sclerosis (MS), transverse myelitis (TM) and Lou Gehrig’s Disease (ALS). Q Therapeutics has previously received venture capital from EPIC Venture Fund, Tucan Capital, and vSpring Capital. posted on Friday, February 15, 2008 (Link to more information)
|
 RSS  Email Twitter
Previous Issues Monday, July 6, 2009 Thursday, July 2, 2009 Wednesday, July 1, 2009 Tuesday, June 30, 2009 Monday, June 29, 2009 |